"Uveitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
| Descriptor ID |
D014605
|
| MeSH Number(s) |
C11.941.879
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Uveitis".
Below are MeSH descriptors whose meaning is more specific than "Uveitis".
This graph shows the total number of publications written about "Uveitis" by people in this website by year, and whether "Uveitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 1 | 4 |
| 2017 | 27 | 6 | 33 |
| 2018 | 19 | 4 | 23 |
| 2019 | 6 | 1 | 7 |
| 2020 | 7 | 0 | 7 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Uveitis" by people in Profiles.
-
COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology Turk J Ophthalmol. 2021 08 27; 51(4):231-242.
-
Late Corneal Stromal Deposits After COVID-19. Cornea. 2021 08 01; 40(8):1067-1069.
-
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence? Int J Infect Dis. 2021 Sep; 110:95-97.
-
Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: Result of the COVID-19-GEAS patient survey. Arch Soc Esp Oftalmol (Engl Ed). 2021 Jul; 96(7):347-352.
-
COVID-19 and Immunosuppressive Therapy in Ocular Inflammatory Disease, a Telemedicine Survey. Ocul Immunol Inflamm. 2021 May 19; 29(4):734-740.
-
COVID-19 related multi-inflammatory syndrome presenting with uveitis - A case report. Indian J Ophthalmol. 2021 05; 69(5):1319-1321.
-
Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic. Indian J Ophthalmol. 2021 05; 69(5):1351-1353.
-
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group. Front Immunol. 2021; 12:656362.
-
Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and Beyond. Semin Ophthalmol. 2021 May 19; 36(4):296-303.
-
Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY). Br J Ophthalmol. 2022 01; 106(1):97-101.